Beth Davis

Dr. Beth Davis serves as a Research Scientist at the University of Saskatchewan within the Respirology, Critical Care and Sleep Medicine division since 2010. She is affiliated with the Asthma Research Lab, where she conducts clinically focused respiratory research.

Education:

• PhD, University of Saskatchewan, 2010
• AllerGen Network Centres of Excellence HQP Trainee, 2010

Her research program centers on asthma pathophysiology with three specialized domains: bronchoprovocation techniques using direct and indirect airway challenges, quantitative airway inflammation measurement via sputum analysis and exhaled nitric oxide, and clinical trials (Phases II-IV) targeting allergic asthma therapeutics. This work directly informs diagnostic protocols and treatment development.

Analysis of her 2009-2011 publications reveals consistent methodological rigor in evaluating novel asthma interventions. Key themes include biologic therapies (IL-13 blockade), refinement of bronchoprovocation testing standards, and combination drug efficacy studies. Her research consistently involves multi-center trial designs with national collaborators.

While specific grant details aren't provided, her active publication record in high-impact respiratory journals indicates sustained research funding. Dr. Davis likely mentors technical staff and research coordinators within the clinical lab environment, though formal student supervision isn't documented.

The Asthma Research Lab under her direction provides specialized infrastructure for airway challenge testing and inflammation biomarker analysis. The lab facilitates translational research connecting clinical observations with physiological mechanisms in asthma.